Physician profile
Michael Cutshall
NPI 1255829396
$5,808.15
in general payments reported to CMS, 2019-2025
11 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $4,065 · 2024: $1,274 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $2,230 · Travel and Lodging: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $2,229.75 |
| Travel and Lodging | $1,078.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,843.24 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $284.50 | 2024-2025 | Stratafix, Megadyne, Echelon; Endopath |
| W. L. Gore & Associates, INC. | $188.32 | 2023-2024 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Medtronic, INC. | $154.36 | 2023-2024 | Parietene Ds, Ligasure |
| Integra Lifesciences Corporation | $104.34 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Innovation Technologies INC | $74.66 | 2024 | Irrisept |
| Conmed Corporation | $66.04 | 2024 | Airseal |
| La Jolla Pharmaceutical Company | $26.61 | 2024 | Xerava |
| Hologic Sales and Service, LLC | $24.94 | 2025 | Magtrace |
| Sanara Medtech INC. | $20.71 | 2024 | Celleraterx |
| Ferring Pharmaceuticals INC. | $20.43 | 2023 | Rebyota |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cutshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.